GlassScriptPhysician profile
Chadalavada Kishore
NPI 1891788741
$1,376.06
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $369 · 2021: $135 · 2022: $33.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $198.70 | 2019-2020 | |
| Pfizer INC. | $157.14 | 2019-2021 | |
| Glaxosmithkline, LLC. | $131.66 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $101.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $92.35 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $85.80 | 2019-2020 | |
| Amgen INC. | $74.48 | 2019-2020 | |
| Astellas Pharma US INC | $58.40 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $51.57 | 2019-2020 | |
| Lilly USA, LLC | $50.70 | 2019 | |
| Merck Sharp & Dohme LLC | $48.16 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.67 | 2019 | |
| Amarin Pharma, INC. | $38.51 | 2019-2020 | |
| Janssen Biotech, INC. | $34.36 | 2021-2022 | |
| Abbott Laboratories | $29.19 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.22 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $27.60 | 2020-2021 | |
| Viiv Healthcare Company | $21.82 | 2021 | |
| Abbvie INC. | $17.86 | 2020 | |
| Kvk-Tech, INC. | $16.95 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.59 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.77 | 2019 | |
| Radius Health, INC. | $14.02 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.77 | 2019 | |
| Allergan, INC. | $12.46 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadalavada Kishore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.